Search In this Thesis
   Search In this Thesis  
العنوان
Molecular Design and Synthesis of Fused Pyrimidine Derivatives with Potential Anti-Cancer Activity
المؤلف
Ali Saleh G. Abdallah,Khaled
هيئة الاعداد
مشرف / Dalal A. Abou El-Ella
باحث / Khaled Ali Saleh G. Abdallah
مشرف / Khaled A. M. Abouzid
مشرف / Mahmoud M.A. Hassan
الموضوع
Epidermal growth factor receptors tyrosine kinases (EGFR TKs) and EGFR TK inhibitors.
تاريخ النشر
2010.
عدد الصفحات
306.P؛
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
الصيدلة ، علم السموم والصيدلانيات (المتنوعة)
تاريخ الإجازة
1/1/2010
مكان الإجازة
جامعة عين شمس - كلية الصيدلة - Pharmaceutical Chemistry
الفهرس
Only 14 pages are availabe for public view

from 206

from 206

Abstract

In recent years, 4-anilinoquinazolines have emerged as a versatile template for inhibition of a diverse range of receptor tyrosine kinases. Epidermal growth factor receptor tyrosine kinase (EGFR-TK) inhibitors are the most widely studied compounds among all tyrosine kinases. In this work, we present a new sub-family of compounds containing 4-anilinoquinazoline, core as promising potent and selective EGFR inhibitors. Our strategy is directed toward designing a variety of ligands with bulky substituents at the anilino moiety, mimicking that of Lapatinib which is recently launched as potent inhibitor for both EGFR and erbB2.
Three series of new 6,7-dimethoxy-4-substituted-anilino-quinazolines (Xa-i, XIa-g, XII) were designed and synthesized from 4,5-dimethoxyanthranilic acid. EGFR inhibitory activity of the final compounds was assessed. Moreover, the in vitro activities of the most active hits were assessed on human breast carcinoma cell line (MCF-7) where the EGFR is highly expressed. Fortunately, compound XIb and XIg displayed highest activity for cell line test. Finally, the active hits and some of the inactive ones were docked to the active site pocket of the EGFR-TK enzyme for investigation of their binding mode to the receptor active site.
This thesis comprises the synthesis of the following unavailable unreported starting materials and intermediates:-
1) m-(3-Methylbenzyloxy)acetanilide (VId)
2) m-(2-(Morpholin-4-yl)ethoxy)acetanilide (VIf)
3) m-(3-Fluorobenzyloxy)acetanilide (VIg)
4) 4-(3-Carboxyanilino)-2-chloro-6,7-dimethoxyquinazoline (VIII).
xiv | A b s t r a c t
In addition the study comprises the synthesis of the following new compounds:-
1) 2-Chloro-6,7-dimethoxy-4-(3-(morpholin-4-ylcarbonyl) anilino)quinazoline (Xa)
2) 2-Chloro-4-(3-(cyclohexylaminocarbonyl)anilino)-6,7-di methoxyquinazoline (Xb)
3) 4-(3-(Benzylaminocarbonyl)anilino)-2-chloro-6,7-dimeth oxyquinazoline (Xc)
4) 2-Chloro-6,7-dimethoxy-4-(3-((ethyl piperazin-1-ylcarbox-ylate)-4-ylcarbonyl)anilino)quinazoline (Xd)
5) 2-Chloro-6,7-dimethoxy-4-(3-(piperidin-1-ylcarbonyl)ani-lino)quinazoline (Xe)
6) 2-Chloro-6,7-dimethoxy-4-((3-(2-phenylethyl)aminocarbon-yl)anilino)quinazoline (Xf)
7) 2-Chloro-6,7-dimethoxy-4-(3-(isopropylaminocarbonyl)an-ilino)quinazoline (Xg)
8) 2-Chloro-6,7-dimethoxy-4-(3-(t-butylaminocarbonyl)anil-ino)quinazoline (Xh)
9) 2-Chloro-6,7-dimethoxy-4-(3-((1-phenylpiperazin)-4-ylcarb-onyl)anilino)quinazoline (Xi)
10) 4-(3-(Benzyloxy)anilino)-2-chloro-6,7-dimethoxyquinazol-ine (XIa)
11) 4-(3-(Allyloxy)anilino)-2-chloro-6,7-dimethoxyquinazoline (XIb)
12) 2-Chloro-4-(3-(3,4-dichlorobenzyloxy)anilino)-6,7-dimeth-oxyquinazoline (XIc)
13) 2-Chloro-6,7-dimethoxy-4-(3-(3-methylbenzyloxy)anilino) quinazoline (XId)
xv | A b s t r a c t
14) 4-(4-(Benzyloxy)anilino)-2-chloro-6,7-dimethoxyquinazo-line (XIe)
15) 2-Chloro-6,7-dimethoxy-4-(3-(2-(morpholin-4-yl)ethoxy)an-ilino)quinazoline (XIf)
16) 2-Chloro-4-(3-(3-fluorobenzyloxy)anilino)-6,7-dimethoxy- quinazoline (XIg)
17) 4-(3-(Benzyloxy)anilino)-6,7-dimethoxyquinazolin-2(1H)-one (XII)
The structures of the synthesized compounds were confirmed by the spectral and micro-analytical analysis. Additionally, the references reviewed were listed at the end of thesis & the whole thesis was summarized in Arabic.